image
Eagle Pharmaceuticals, Inc. EGRX
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 0.9
12.7 %
$ 11.7 M
Market Cap
1.06
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2022-12-31 84.56% 513.14% 1935.02%
Annual Report FY 10-K 2021-12-31 -8.66% -71.96% -11.53%
Annual Report FY 10-K 2020-12-31 -4.13% -16.24% 15.76%
Annual Report FY 10-K 2019-12-31 -8.17% -55.14% -40.42%
Annual Report FY 10-K 2018-12-31 -9.88% -38.58% -50.51%
Annual Report FY 10-K 2017-12-31 24.92% -36.23% 38.69%
Annual Report FY 10-K 2016-12-31 186.11% 3068.14% 1984.02%
Annual Report FY 10-K 2015-12-31 246.76% 114.30% 113.65%
Annual Report FY 10-K 2014-09-30 39.62% -197.22% -121.84%
Annual Report FY 10-K 2013-09-30 438.75% 68.79% 57.36%
Annual Report FY 10-K 2012-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2023-06-30 -12.80% 154.65% 367.73%
Quarterly Report Q1 8-K 2023-03-31 -42.78% -86.95% -89.66%
Quarterly Report Q4 8-K 2022-12-31 43.43% 231.78% 60.47%
Quarterly Report Q3 8-K 2022-09-30 65.36% 37.51% 77.34%
Quarterly Report Q2 8-K 2022-06-30 54.05% -261.63% -79.64%
Quarterly Report Q1 8-K 2022-03-31 180.91% 10565.08% 1685.71%
Quarterly Report Q4 8-K 2021-12-31 -15.22% -76.90% -39.76%
Quarterly Report Q3 8-K 2021-09-30 -20.18% -79.64% -66.01%
Quarterly Report Q2 8-K 2021-06-30 14.75% 1510.94% 191.72%
Quarterly Report Q1 8-K 2021-03-31 -10.37% 85.34% -93.51%
Quarterly Report Q4 8-K 2020-12-31 3.44% 701.69% 238.04%
Quarterly Report Q3 8-K 2020-09-30 21.34% 395.36% 720.65%
Quarterly Report Q2 8-K 2020-06-30 -26.04% -3.81% -59.83%
Quarterly Report Q1 8-K 2020-03-31 -7.56% -32.00% -66.84%
Quarterly Report Q4 8-K 2019-12-31 -13.91% -92.02% -81.58%
Quarterly Report Q3 8-K 2019-09-30 -19.85% -17.02% -13.50%
Quarterly Report Q2 8-K 2019-06-30 -4.37% 152.91% 4945.36%
Quarterly Report Q1 8-K 2019-03-31 6.78% 243.00% 427.94%
Quarterly Report Q4 8-K 2018-12-31 19.81% 38.58% 50.66%
Quarterly Report Q3 8-K 2018-09-30 -18.54% -9.01% -26.24%
Quarterly Report Q2 8-K 2018-06-30 18.34% -40.95% -96.90%
Quarterly Report Q1 8-K 2018-03-31 -39.28% -88.59% -92.95%
Quarterly Report Q4 8-K 2017-12-31 -42.34% -84.15% -63.09%
Quarterly Report Q3 8-K 2017-09-30 66.58% 29.11% 102.71%
Quarterly Report Q2 8-K 2017-06-30 22.46% -65.62% -56.78%
Quarterly Report Q1 8-K 2017-03-31 159.51% 2658.48% 3745.04%
Quarterly Report Q4 8-K 2016-12-31 346.30% 4600.66% 2271.00%
Quarterly Report Q3 8-K 2016-09-30 559.57% 217.56% 218.48%
Quarterly Report Q2 8-K 2016-06-30 581.74% 260.19% 263.84%
Quarterly Report Q1 8-K 2016-03-31 -18.50% -4.55% -4.46%
Quarterly Report Q4 8-K 2015-12-31 224.66% 122.14% 118.17%
Quarterly Report Q3 8-K 2015-09-30 104.06% -11.68% -14.08%
Quarterly Report Q2 8-K 2015-06-30 3.63% -178.69% -179.47%
Quarterly Report Q1 8-K 2015-03-31 625.49% 833.78% 657.59%
Quarterly Report Q4 8-K 2014-12-31 1.97% -69.15% -114.16%
Quarterly Report Q3 8-K 2014-09-30 -39.42% -1883.60% -259.74%
Quarterly Report Q2 8-K 2014-06-30 14.12% -388.84% -236.75%
Quarterly Report Q1 8-K 2014-03-31 101.74% 44.12% 16.33%
Quarterly Report Q4 8-K 2013-12-31 270.28% -31.12% -6.53%
Quarterly Report Q3 8-K 2013-09-30 255.27% 109.30% 35.39%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2012-09-30 0.00% 0.00% 0.00%